MA35742B1 - Dérivés de n- (4 -quinolinylmethyl) sulfonamide et leur utilisation en tant qu'antihelminthiques - Google Patents

Dérivés de n- (4 -quinolinylmethyl) sulfonamide et leur utilisation en tant qu'antihelminthiques

Info

Publication number
MA35742B1
MA35742B1 MA37145A MA37145A MA35742B1 MA 35742 B1 MA35742 B1 MA 35742B1 MA 37145 A MA37145 A MA 37145A MA 37145 A MA37145 A MA 37145A MA 35742 B1 MA35742 B1 MA 35742B1
Authority
MA
Morocco
Prior art keywords
antihelminthics
quinolinylmethyl
sulfonamide
derivatives
compounds
Prior art date
Application number
MA37145A
Other languages
English (en)
Inventor
George Philip Lahm
Moumita Kar
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of MA35742B1 publication Critical patent/MA35742B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

L'invention concerne des composés de formule 1, leurs
MA37145A 2011-11-28 2014-06-23 Dérivés de n- (4 -quinolinylmethyl) sulfonamide et leur utilisation en tant qu'antihelminthiques MA35742B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161563926P 2011-11-28 2011-11-28
PCT/US2012/063802 WO2013081783A1 (fr) 2011-11-28 2012-11-07 Dérivés de n- (4 -quinolinylmethyl) sulfonamide et leur utilisation en tant qu'antihelminthiques

Publications (1)

Publication Number Publication Date
MA35742B1 true MA35742B1 (fr) 2014-12-01

Family

ID=47179004

Family Applications (1)

Application Number Title Priority Date Filing Date
MA37145A MA35742B1 (fr) 2011-11-28 2014-06-23 Dérivés de n- (4 -quinolinylmethyl) sulfonamide et leur utilisation en tant qu'antihelminthiques

Country Status (20)

Country Link
US (1) US20140315857A1 (fr)
EP (1) EP2785694A1 (fr)
JP (1) JP2015502936A (fr)
KR (1) KR20140094026A (fr)
CN (1) CN103958476A (fr)
AR (1) AR089014A1 (fr)
AU (1) AU2012346433A1 (fr)
BR (1) BR112014012759A8 (fr)
CA (1) CA2855001A1 (fr)
CL (1) CL2014001377A1 (fr)
CO (1) CO6980661A2 (fr)
IL (1) IL232404A0 (fr)
MA (1) MA35742B1 (fr)
MX (1) MX2014006317A (fr)
PH (1) PH12014501181A1 (fr)
RU (1) RU2014126367A (fr)
SG (1) SG11201402664VA (fr)
TN (1) TN2014000166A1 (fr)
TW (1) TW201326128A (fr)
WO (1) WO2013081783A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2014065411A1 (ja) * 2012-10-26 2016-09-08 株式会社エス・ディー・エス バイオテック 農園芸用の有害生物防除剤としてのスルホンアミド誘導体
WO2014099837A1 (fr) * 2012-12-18 2014-06-26 E. I. Du Pont De Nemours And Company Sulfonamide anti-helminthique
SI3538512T1 (sl) * 2016-11-11 2021-09-30 Bayer Animal Health Gmbh Novi antihelmintični kinolin-3-karboksamidni derivati
US11485733B2 (en) * 2017-06-30 2022-11-01 Bayer Animal Health Gmbh Azaquinoline derivatives
EP4291555A1 (fr) * 2021-02-09 2023-12-20 Celgene Corporation Sulfamides et leur utilisation pour le traitement d'infections et de maladies helminthiques
WO2023122212A2 (fr) 2021-12-21 2023-06-29 Southern Research Institute Phényléthynyl pyridine carboxamides substitués en tant qu'inhibiteurs puissants du virus du sras

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1815604A (en) 1922-10-31 1931-07-21 Winthrop Chem Co Organic mercury compound
US1679404A (en) 1926-02-04 1928-08-07 Rockwood Sprinkler Co Massachusetts Constant-alarm device for alarm valves
US1959705A (en) 1931-08-12 1934-05-22 Standard Steel Car Corp Car door
US5299582A (en) 1991-09-16 1994-04-05 Little Rapids Corporation Surgical isolation apparatus
US5399582A (en) 1993-11-01 1995-03-21 Merck & Co., Inc. Antiparasitic agents
US5595991A (en) 1995-03-20 1997-01-21 Merck & Co., Inc. Anthelmintic use of nodulisporic acid and analogs thereof
US5962499A (en) 1995-03-20 1999-10-05 Merck & Co., Inc. Nodulisporic acid derivatives
PL185563B1 (pl) 1995-03-20 2003-06-30 Merck & Co Inc Pochodne kwasu nodulisporowego oraz zawierające je kompozycje farmaceutyczne
US6221894B1 (en) 1995-03-20 2001-04-24 Merck & Co., Inc. Nodulisporic acid derivatives
US5958888A (en) 1996-07-02 1999-09-28 Merial, Inc. Water miscible macrolide solutions
US6271255B1 (en) 1996-07-05 2001-08-07 Biotica Technology Limited Erythromycins and process for their preparation
US5834260A (en) 1996-08-30 1998-11-10 Merck & Co., Inc. Antiparasitic agents
US6339063B1 (en) 1997-09-10 2002-01-15 Merck & Co., Inc. 9a-azalides as veterinary antimicrobial agents
JP2003512290A (ja) 1997-09-10 2003-04-02 メルク エンド カムパニー インコーポレーテッド 家畜抗菌剤としての８ａ−アザライド
AP9801420A0 (en) 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
US6136838A (en) 1998-03-19 2000-10-24 Merck & Co., Inc. Sulfurpentafluorophenylpyrazoles for controlling ectoparasitic infestations
US6239112B1 (en) 1998-07-09 2001-05-29 Merial, Inc. Water miscible macrolide solutions
CA2411293A1 (fr) 1999-01-28 2000-07-28 Pfizer Products Inc. Nouveaux azalides et procede de fabrication
BRPI0017013B1 (pt) 2000-01-27 2015-07-14 Zoetis P Llc Composição de antibiótico azalídeo e método para sua obtenção
US6399796B2 (en) 2000-03-17 2002-06-04 Roche Vitamins Inc. Activation of a Diels-Alder reaction of a sterol 5,7-diene
WO2003077828A2 (fr) 2002-03-08 2003-09-25 Schering-Plough, Ltd. Antibiotiques de type florfenicol
AP2006003564A0 (en) * 2003-09-18 2006-04-30 Basf Ag 4-Pridinylmethylsulphonamide derivatives as fungicidal plant protection agents.
AR046970A1 (es) 2003-12-23 2006-01-04 Schering Plough Ltd Esteres de fosfato de florfenicol
US7361689B2 (en) 2003-12-31 2008-04-22 Schering-Plough Animal Health Corporation Antibacterial 1-(4-mono- and di-halomethylsulphonylphenyl)-2-acylamino-3-fluoroproponals and preparation thereof
BRPI0418328A (pt) 2003-12-31 2007-05-02 Schering Plough Ltd controle de parasitas em animais pelo uso de derivados de imidazo [1,2-b]piridazina
EP1571150A1 (fr) 2004-03-02 2005-09-07 Aventis Pharma Deutschland GmbH Procédé pour la prparation des inhibiteurs de tryptase
AU2005286723A1 (en) 2004-09-23 2006-03-30 Schering-Plough Pty. Limited Control of parasites in animals by the use of novel trifluoromethanesulfonanilide oxime ether derivatives
US7642391B1 (en) 2005-03-04 2010-01-05 Iowa State University Research Foundation, Inc. Palladium-catalyzed coupling of aryl halides with alkynes
EA012627B1 (ru) 2005-03-16 2009-10-30 Басф Акциенгезельшафт N-(4-пиридил)метилсульфонамиды для борьбы с членистоногими вредителями
CA2609574A1 (fr) 2005-06-09 2006-12-21 Schering-Plough Ltd. Controle de parasites chez des animaux a l'aide de derives de n-[(phenyloxy)phenyl]-1,1,1-trifluoromethanesulfonamide et de n-[(phenylsulfanyl)phenyl]-1,1,1-trifluoromethanesulfonamide
US20070285554A1 (en) 2005-10-31 2007-12-13 Dor Givon Apparatus method and system for imaging
NZ570666A (en) * 2006-02-14 2010-09-30 Basf Se Pyridin-4-ylmethylsulphonamides for combating pests
MX2008011531A (es) 2006-03-15 2008-09-18 Basf Se Derivados de quinolina y su uso como pesticidas.
AU2007263075A1 (en) 2006-06-20 2007-12-27 F. Hoffmann-La Roche Ag Arylsulfonamidyl tetralin derivatives and uses thereof
EP2044018A1 (fr) 2006-07-11 2009-04-08 Pfizer Japan, Inc. Composés de carboxyamide bicycliques à n-bicycloalkyle substitué
KR20090064448A (ko) * 2006-09-12 2009-06-18 바스프 에스이 퀴놀리닐메틸 화합물
EP2118088B1 (fr) 2006-12-20 2012-05-30 Amgen Inc. Composés hétérocycliques et leur utilisation dans le traitement d'inflammation, de l'angiogenèse et du cancer
WO2008090434A1 (fr) 2007-01-25 2008-07-31 Pfizer Japan Inc. Composés n-bicyclicalkyle bicyclique carboxyamide substitués
TWI482771B (zh) * 2009-05-04 2015-05-01 Du Pont 磺醯胺殺線蟲劑
CN103619818A (zh) * 2011-06-20 2014-03-05 纳幕尔杜邦公司 用于治疗蠕虫感染的杂环化合物

Also Published As

Publication number Publication date
BR112014012759A2 (pt) 2017-06-13
PH12014501181A1 (en) 2014-09-08
JP2015502936A (ja) 2015-01-29
CN103958476A (zh) 2014-07-30
RU2014126367A (ru) 2016-01-27
KR20140094026A (ko) 2014-07-29
TN2014000166A1 (en) 2015-09-30
IL232404A0 (en) 2014-06-30
AR089014A1 (es) 2014-07-23
SG11201402664VA (en) 2014-06-27
CL2014001377A1 (es) 2014-10-17
US20140315857A1 (en) 2014-10-23
MX2014006317A (es) 2014-06-23
WO2013081783A1 (fr) 2013-06-06
TW201326128A (zh) 2013-07-01
CA2855001A1 (fr) 2013-06-06
EP2785694A1 (fr) 2014-10-08
AU2012346433A1 (en) 2014-05-08
BR112014012759A8 (pt) 2017-06-20
CO6980661A2 (es) 2014-06-27

Similar Documents

Publication Publication Date Title
MA37959A2 (fr) Dérivés de 5-phénoxy-3h-pyrimidin-4-one et leur utilisation en tant qu'inhibiteurs de la transcriptase inverse du vih
MA37142A3 (fr) Dérivés de dihydro-benzo-oxazine et de dihydro-pyrido-oxazine
MA35926B1 (fr) Pyrrolidine-2-carboxamides substitués
MA37519A1 (fr) Composés et compositions pour inhiber l'activité d'abl1, abl2 et bcr-abl1
EA201590999A1 (ru) Пирролобензодиазепины и их конъюгаты
EA201492023A1 (ru) Регуляторы пути комплемента и их применение
UA114611C2 (uk) Пестицидні композиції і способи, що їх стосуються
MA35086B1 (fr) Compose de triazolopyridine
MA35905B1 (fr) Composés de bêta-lactame à substitution amidine, leur préparation et leur utilisation en tant qu'agents antibactériens
MA35089B1 (fr) Inhibiteurs de la production de leucotrienes de type benzodioxane
MA35357B1 (fr) Composes de type anilines
MA35819B1 (fr) Composés hétéroaryl pyridones et aza-pyridones en tant qu'inhibiteurs de l'activité btk
MA38645B1 (fr) Nouveaux inhibiteurs de cyp17/antiandrogènes
MA34963B1 (fr) Derives de fluoro-pyridinone utiles en tant qu'agents antibacteriens
TR201900038T4 (tr) GPR6'nın tetrahidropiridopirazin modülatörleri.
MA35742B1 (fr) Dérivés de n- (4 -quinolinylmethyl) sulfonamide et leur utilisation en tant qu'antihelminthiques
EA201400976A1 (ru) Бензодиоксаны в комбинации с другими активными средствами для ингибирования продуцирования лейкотриена
EA201590854A1 (ru) Пиридин-2-амиды, пригодные в качестве агонистов каннабиноидного рецептора 2
CR20130501A (es) Derivados novedosos de cefalosporinas y composiciones farmacéuticas de estos
UA107455C2 (uk) Похідні індолу як протиракові агенти
EA201791321A1 (ru) Составы ингибитора lfa-1
CR20140322A (es) Nuevos derivados de bencil sulfonamida útiles como inhibidores de mogat-2
TR201902057T4 (tr) Tetrasiklin bileşikleri.
MA40250A (fr) Dérivés de quinolizinone utilisés comme inhibiteurs de pi3k
CL2013003068A1 (es) Compuestos derivados de 2-(etinil-piridin-2-il)-pirazolidin-3-ona, 2-(etinil-pirimidin-2-il)-pirazolidin-3-ona o 2-(etinil-piridazin-3-il)-pirazolidin-3-ona; moduladores alostericos positivos de mglur5; procedimiento de preparacion; composicion farmaceutica; y su uso para tratar la esquizofrenia o enfermedades cognitivas.